[ad_1] European drug regulators on Friday rejected the Alzheimer’s treatment Leqembi from Biogen and Eisai, creating…
Tag: Pharmaceuticals
Pfizer moves forward with once-daily version of weight loss pill after setbacks
[ad_1] Sopa Images | Lightrocket | Getty Images Pfizer on Thursday said it will move forward…
Novo Nordisk shares shrug off concerns over study linking weight loss drugs to rare eye condition
[ad_1] A box of Ozempic and contents sit on a table in Dudley, North Tyneside, Britain,…
FDA approves Eli Lilly Alzheimer’s drug, expanding treatment options in the U.S.
[ad_1] A sign with the company logo sits outside of the headquarters campus of Eli Lilly…
FDA approval of Eli Lilly’s Alzheimer’s drug cements our decision not to take profits
[ad_1] Every weekday, the CNBC Investing Club with Jim Cramer releases the Homestretch — an actionable…
Pfizer struggles to claw back faith with Wall Street and its employees as it recovers from the Covid decline
[ad_1] Kena Betancur | Corbis News | Getty Images Pfizer had a “phenomenal” first quarter —…
Walgreens stock plunges as drugstore chain slashes profit guidance in ‘challenging’ consumer environment
[ad_1] In an aerial view, a customer enters a Walgreens store on January 04, 2024 in…
Novo Nordisk to build $4.1 billion North Carolina facility to boost output of Wegovy, Ozempic
[ad_1] Novo Nordisk’s new manufacturing facility in Clayton, North Carolina. Courtesy: Novo Nordisk Novo Nordisk on…
Eli Lilly expects FDA decision on weight loss drug Zepbound for sleep apnea as early as end of the year
[ad_1] Eli Lilly on Friday said it applied for U.S. approval of its weight loss drug Zepbound for…
FDA approves Merck vaccine designed to protect adults from bacteria that can cause pneumonia, serious infections
[ad_1] Zoom In IconArrows pointing outwards Merck’s new pneumococcal vaccine. Courtesy: Merck The Food and Drug…
How Eli Lilly is managing soaring demand for GLP-1s, according to outgoing CFO Anat Ashkenazi
[ad_1] A pharmacist holds boxs of Eli Lilly & Co. Mounjaro brand tirzepatide medication arranged at…
Jim Cramer says the best is yet to come at Oracle — plus, his thoughts on 4 more stocks
[ad_1] Jim Cramer’s daily rapid fire looks at stocks in the news outside the CNBC Investing…